A qualitative meta-synthesis of pregnant women's experiences of accessing and receiving treatment for opioid use disorder.
medication-assisted treatment
meta-analysis
opioid use disorder
pregnancy
substance use treatment
Journal
Drug and alcohol review
ISSN: 1465-3362
Titre abrégé: Drug Alcohol Rev
Pays: Australia
ID NLM: 9015440
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
revised:
12
11
2021
received:
16
06
2021
accepted:
13
11
2021
pubmed:
18
1
2022
medline:
4
5
2022
entrez:
17
1
2022
Statut:
ppublish
Résumé
Addressing opioid use disorder (OUD) among pregnant women is of growing importance, and substance use treatment positively impacts outcomes for mother and baby. Understanding substance use treatment experiences is important to improve access, and retention, and no review or synthesis of research addressing the treatment experiences of pregnant women exists. Thus, a qualitative meta-synthesis was conducted, which investigated the psychological motivators and barriers of pregnant women with OUD trying to access treatment and their perceptions of treatment. A total of 3844 articles were retrieved from the literature search. Nine articles met eligibility criteria, were appraised, then synthesised using a comparative thematic approach. Four themes: (i) Embodied Experiences; (ii) Institutional Pressures; (iii) Social Context; and (iv) Reconstructing Selves; indicate that women with OUD are motivated to engage in treatment to pursue the safety and custody of the unborn baby and to pursue and enact the changes necessary to claim 'normal' parenthood status. Pregnant women describe psychological and relational barriers to engaging in treatment, including anxieties about the baby's health, fears of authorities' involvement, stigma and experiencing relationships with treatment providers as constrictive or invalidating. Identity theory's concepts of identity verification, closed environments and master status identities illuminate the findings. Implications include recognising the salience of bodily experiences, providing medication-assisted treatment support groups and promoting validating relationships in treatment using strengths-based approaches. Pregnant women face unique psychological challenges in accessing and engaging in substance use treatment for OUD.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
851-862Informations de copyright
© 2022 Australasian Professional Society on Alcohol and other Drugs.
Références
SAMHSA. Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants [Internet]. 2018. Available at: https://store.samhsa.gov/product/Clinical-Guidance-for-Treating-Pregnant-and-Parenting-Women-With-Opioid-Use-Disorder-and-Their-Infants/SMA18-5054 (accessed 20 April 2020).
Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid use disorder documented at delivery hospitalization-United States, 1999-2014. MMWR Morb Mortal Wkly Rep 2018;67:845-9.
Ludlow JP, Evans SF, Hulse G. Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse. Aust N Z J Obstet Gynaecol 2004;44:302-6.
Park EM, Meltzer-Brody S, Suzuki J. Evaluation and management of opioid dependence in pregnancy. Psychosomatics 2012;53:424-32.
Kocherlakota P. Neonatal abstinence syndrome. Pediatrics 2014;134:547-61.
Johnson E. Models of care for opioid dependent pregnant women. In: Seminars in perinatology, Vol. 43. Philadelphia, PA: WB Saunders, 2019:132-40.
American College of Obstetricians and Gynaecologists (ACOG) Committee on Health Care for Underserved Women. ACOG Committee Opinion No. 524: opioid abuse, dependence, and addiction in pregnancy. Obstet Gynecol 2012;119:1070-6.
Jones HE, O'Grady KE, Malfi D, Tuten M. Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict 2008;17:372-86.
Terplan M, Laird HJ, Hand DJ et al. Opioid detoxification during pregnancy: a systematic review. Obstet Gynecol 2018;131:803-14.
Jancaitis B, Kelpin S, Masho S, May J, Haug NA, Svikis D. Factors associated with treatment retention in pregnant women with opioid use disorders prescribed methadone or electing non-pharmacological treatment. Women Health 2020;60:1-11.
National Academies of Sciences, Engineering, and Medicine. Medications for opioid use disorder save lives. Washington, DC: National Academies Press, 2019.
Jones HE, Martin PR, Heil SH et al. Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat 2008;35:245-59.
Randall E, Vanderplasschen W. Gender differences. In: Vanderplasschen W, De Maeyer J, Colpaert K et al., eds. Poly substance use and mental health among individuals presenting for substance abuse treatment. London: Academia Press, 2012:60-77.
Terplan M, Kennedy-Hendricks A, Chisolm MS. Article commentary: prenatal substance use: exploring assumptions of maternal unfitness. Subst Abuse 2015;9(Suppl 2):1-4.
Brady KT, Randall CL. Gender differences in substance use disorders. Psychiatr Clin North Am 1999;22:241-52.
Kirtadze I, Otiashvili D, O'Grady KE et al. Twice stigmatized: provider's perspectives on drug-using women in the Republic of Georgia. J Psychoactive Drugs 2013;45:1-9.
Kulesza M, Larimer ME, Rao D. Substance use related stigma: what we know and the way forward. J Addict Behav Ther Rehabil 2013;2:782.
Wong S, Ordean A, Kahan M et al. Substance use in pregnancy. J Obstet Gynaecol Can 2011;33:367-84.
Klee H, Jackson M, Lewis S, eds. Drug misuse and motherhood. Hove, UK: Psychology Press, 2002.
Poole N, Isaac B. Apprehensions: barriers to treatment for substance-using mothers. Vancouver: British Columbia Centre of Excellence for Women's Health, 2001.
Stone R. Pregnant women and substance use: fear, stigma, and barriers to care. Health Justice 2015;3:2.
Webster F, Rice K, Sud A. A critical content analysis of media reporting on opioids: the social construction of an epidemic. Soc Sci Med 2020;244:112642.
Brown SA. Stigma towards marijuana users and heroin users. J Psychoactive Drugs 2015;47:213-20.
Radcliffe P, Stevens A. Are drug treatment services only for ‘thieving junkie scumbags’? Drug users and the management of stigmatised identities. Soc Sci Med 2008;67:1065-73.
Jordan CJ, Cao J, Newman AH, Xi ZX. Progress in agonist therapy for substance use disorders: lessons learned from methadone and buprenorphine. Neuropharmacology 2019;158:107609.
Fox AD, Maradiaga J, Weiss L, Sanchez J, Starrels JL, Cunningham CO. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder. Addict Sci Clin Pract 2015;10:2.
Yarborough BJ, Stumbo SP, McCarty D, Mertens J, Weisner C, Green CA. Methadone, buprenorphine and preferences for opioid agonist treatment: a qualitative analysis. Drug Alcohol Depend 2016;160:112-8.
Chandler A, Whittaker A, Cunningham-Burley S, Williams N, McGorm K, Mathews G. Substance, structure and stigma: parents in the UK accounting for opioid substitution therapy during the antenatal and postnatal periods. Int J Drug Policy 2013;24:35-42.
Ostrach B, Leiner C. “I didn't want to be on Suboxone at first…” - ambivalence in perinatal substance use treatment. J Addict Med 2019;13:264-71.
Prince MK, Ayers D. Substance use in pregnancy. Treasure Island, FL: StatPearls Publishing, 2020.
Kissin WB, Svikis DS, Moylan P, Haug NA, Stitzer ML. Identifying pregnant women at risk for early attrition from substance abuse treatment. J Subst Abuse Treat 2004;27:31-8.
Lester BM, Twomey JE. Treatment of substance abuse during pregnancy. Womens Health 2008;4:67-77.
Nosyk B, Marsh DC, Sun H, Schechter MT, Anis AH. Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996-2006. J Subst Abuse Treat 2010;39:22-31.
Haller DL, Miles DR, Dawson KS. Factors influencing treatment enrollment by pregnant substance abusers. Am J Drug Alcohol Abuse 2003;29:117-31.
Horsfall J, Cleary M, Hunt GE, Walter G. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence. Harv Rev Psychiatry 2009;17:24-34.
Weisdorf T, Parran TV Jr, Graham A, Snyder C. Comparison of pregnancy-specific interventions to a traditional treatment program for cocaine-addicted pregnant women. J Subst Abuse Treat 1999;16:39-45.
Milligan K, Niccols A, Sword W et al. Maternal substance use and integrated treatment programs for women with substance abuse issues and their children: a meta-analysis. Subst Abuse Treat Prev Policy 2010;5:21.
Jessup MA, Humphreys JC, Brindis CD, Lee KA. Extrinsic barriers to substance abuse treatment among pregnant drug dependent women. J Drug Issues 2003;33:285-304.
Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol 2008;8:45.
Tong A, Flemming K, McInnes E, Oliver S, Craig J. Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res Methodol 2012;12:181.
Cooke A, Smith D, Booth A. Beyond PICO: the SPIDER tool for qualitative evidence synthesis. Qual Health Res 2012;22:1435-43.
Noblit GW, Hare RD, Hare RD. Meta-ethnography: synthesizing qualitative studies. New York, NY: Sage, 1988.
Sandelowski M, Docherty S, Emden C. Qualitative metasynthesis: issues and techniques. Res Nurs Health 1997;20:365-71.
Walsh D, Downe S. Meta-synthesis method for qualitative research: a literature review. J Adv Nurs 2005;50:204-11.
Finlayson KW, Dixon A. Qualitative meta-synthesis: a guide for the novice. Nurse Res 2008;15:59-71.
Mullins N, Ramage M, Ostrach B, Leiner C. Addressing patient fears in perinatal substance use treatment. Obstet Gynecol 2019;134:44.
Titus-Glover D, Shaya FT. The patient experience and buprenorphine use among pregnant and postpartum women. Value Health 2018;21:S128.
Campbell R, Pound P, Pope C et al. Evaluating meta-ethnography: a synthesis of qualitative research on lay experiences of diabetes and diabetes care. Soc Sci Med 2003;56:671-84.
Jackson A, Shannon L. Barriers to receiving substance abuse treatment among rural pregnant women in Kentucky. Matern Child Health J 2012;16:1762-70.
Jackson A, Shannon L. Examining barriers to and motivations for substance abuse treatment among pregnant women: does urban-rural residence matter? Women Health 2012;52:570-86.
Fallin-Bennett A, Elswick A, Ashford K. Peer support specialists and perinatal opioid use disorder: someone that's been there, lived it, seen it. Addict Behav 2020;102:106204.
Mattocks KM, Clark R, Weinreb L. Initiation and engagement with methadone treatment among pregnant and postpartum women. Womens Health Issues 2017;27:646-51.
Howard H. Experiences of opioid-dependent women in their prenatal and postpartum care: implications for social workers in health care. Soc Work Health Care 2016;55:61-85.
Frazer Z, McConnell K, Jansson LM. Treatment for substance use disorders in pregnant women: motivators and barriers. Drug Alcohol Depend 2019;205:107652.
Radcliffe P. Motherhood, pregnancy, and the negotiation of identity: the moral career of drug treatment. Soc Sci Med 2011;72:984-91.
Morris M, Seibold C, Webber R. Drugs and having babies: an exploration of how a specialist clinic meets the needs of chemically dependent pregnant women. Midwifery 2012;28:163-72.
Britten N, Campbell R, Pope C, Donovan J, Morgan M, Pill R. Using meta ethnography to synthesise qualitative research: a worked example. J Health Serv Res Policy 2002;7:209-15.
Critical Appraisal Skills Programme [Internet]. CASP Qualitative Studies Checklist. Available at: https://casp-uk.net/casp-tools-checklists/ (accessed 3 March 2020).
Atkins S, Lewin S, Smith H, Engel M, Fretheim A, Volmink J. Conducting a meta-ethnography of qualitative literature: lessons learnt. BMC Med Res Methodol 2008;8:21.
Vogel D. Narrative perspectives in theory and therapy. J Constr Psychol 1994;7:243-61.
Neiterman E. Doing pregnancy: pregnant embodiment as performance. In: Women's studies international forum, Vol. 35. Oxford, UK: Pergamon, 2012:372-83.
Warren S, Brewis J. Matter over mind? Examining the experience of pregnancy. Sociology 2004;38:219-36.
Goffman E. Stigma: notes on the management of spoiled identity. New York, NY: Simon and Schuster, 2009.
Gross H, Pattison H. Sanctioning pregnancy: a psychological perspective on the paradoxes and culture of research. Abingdon-on-Thames, UK: Routledge, 2007.
Van Boekel LC, Brouwers EP, Van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend 2013;131:23-35.
Madden EF. Intervention stigma: how medication-assisted treatment marginalizes patients and providers. Soc Sci Med 2019;232:324-31.
McCall GJ, Simmons JL. Identities and interactions. New York, NY: Free Press, 1978.
Stets JE, Serpe RT. Identity theory. In: Lindzey G, ed. Handbook of social psychology. New York, NY: Springer, 2013:31-60.
Verissimo AD, Grella CE. Influence of gender and race/ethnicity on perceived barriers to help-seeking for alcohol or drug problems. J Subst Abuse Treat 2017;75:54-61.
Schuckit MA. Treatment of opioid-use disorders. N Engl J Med 2016;375:357-68.
Dingle GA, Cruwys T, Frings D. Social identities as pathways into and out of addiction. Front Psychol 2015;6:1795.
Scorsone KL, Haozous EA, Hayes L, Cox KJ. Overcoming barriers: individual experiences obtaining medication-assisted treatment for opioid use disorder. Qual Health Res 2020;30:2103-17.
Seligman ME, Csikszentmihalyi M. Positive psychology: an introduction. In: Flow and the foundations of positive psychology. Dordrecht: Springer, 2014:279-98.